RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME ISTURISA® is a cortisol synthesis inhibitor that blocks the enzyme 11β-hydroxylase to help normalize hypercortisolemia in Cushing’s syndrome, a rare endocrine condition that can have significant impact on patients and their familiesThe expanded indication is supported by an extensive clini...
Kering: Information regarding the arrangements for taking part in the Combined General Meeting of April 24, 2025 and conditions for obtaining or consulting the documents prepared for the meeting PRESS RELEASEApril 14, 2025 INFORMATION REGARDING THE ARRANGEMENTS FOR TAKING PART IN THE COMBINED GENERAL MEETING OF APRIL 24, 2025 AND CONDITIONS FOR OBTAINING OR CONSULTINGTHE DOCUMENTS PREPARED FOR THE MEETING Kering shareholders are invited to attend the Company’s Combined General Meeting to be held at 3 p.m. on Thursday, April 24, 2025 (Paris time) at Kering’s headquarters – 40 rue de Sèvres...
Kering : Informations relatives aux modalités de tenue de l’Assemblée générale mixte du 24 avril 2025 et modalités de mise à disposition ou de consultation des documents préparatoires COMMUNIQUÉ DE PRESSE14 avril 2025 INFORMATIONS RELATIVES AUX MODALITÉS DE TENUE DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 AVRIL 2025 ET MODALITÉS DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PRÉPARATOIRES Les actionnaires de Kering sont invités à participer à l’Assemblée générale mixte qui se tiendra au siège social de la Société, 40 rue de Sèvres, Paris 7e, le jeudi 24 avril 2025 à 15 heures (heure d...
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at the correlation between robust financial markets and healthy US consumer
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.